Gliclazide 40 mg+Metformin 500 mg
Managing type 2 diabetes requires effective control of blood sugar levels to prevent long-term complications like heart disease, kidney damage, and nerve issues. Gliclaglaze M 40 is a medication designed to help individuals with type 2 diabetes manage their blood glucose levels effectively. This combination therapy contains two powerful ingredients: gliclazide 40 mg and metformin 500 mg. Together, these active compounds work synergistically to control blood sugar levels, improving overall diabetic control and reducing the risk of complications.
Composition of Gliclaglaze M 40: Key Features and Ingredients
Gliclaglaze M 40 combines two key active ingredients:
Gliclazide (40 mg):
- Gliclazide is an oral hypoglycemic agent belonging to the sulfonylurea class. It works by stimulating the pancreas to produce more insulin, which helps lower blood sugar levels after meals. By enhancing insulin secretion, gliclazide helps improve glucose uptake by cells and reduces the amount of sugar circulating in the bloodstream.
- This helps individuals with type 2 diabetes achieve better control over their postprandial glucose (after-meal blood sugar) levels.
Metformin (500 mg):
- Metformin is a biguanide medication that works by reducing hepatic glucose production (the production of sugar by the liver). It also improves the body\'s insulin sensitivity, allowing cells to absorb glucose more efficiently. Metformin helps control fasting blood glucose levels and plays a critical role in improving insulin resistance, a hallmark of type 2 diabetes.
- Additionally, metformin aids in reducing the risk of cardiovascular complications often associated with diabetes.
Together, these two ingredients form a potent combination that helps regulate blood glucose levels throughout the day and improves insulin sensitivity.
Usage of Gliclaglaze M 40
Gliclaglaze M 40 is primarily used in the management of type 2 diabetes. It is typically prescribed when a healthy diet and exercise alone are not sufficient to control blood sugar levels. The medication works well for individuals who require insulin secretion stimulation as well as improved insulin sensitivity.
The usual recommended dosage of Gliclaglaze M 40 is one tablet once or twice a day, depending on the patient\'s needs and the healthcare provider\'s recommendations. It is typically taken with meals to minimize any potential gastrointestinal discomfort. The dosage may be adjusted based on the individual’s blood sugar levels and overall response to treatment.
Key Benefits of Gliclaglaze M 40
Effective Blood Sugar Control:
- Gliclaglaze M 40 helps regulate both fasting and postprandial blood glucose levels, offering comprehensive control over blood sugar throughout the day. This is especially important for individuals with type 2 diabetes who struggle with both insulin resistance and insulin deficiency.
Dual Action Mechanism:
- The combination of gliclazide and metformin offers synergistic effects. Gliclazide increases insulin secretion, while metformin improves insulin sensitivity and reduces sugar production in the liver. Together, they address multiple aspects of diabetic control, leading to more stable blood glucose levels.
Reduces Risk of Long-Term Complications:
- Proper management of blood sugar levels with Gliclaglaze M 40 helps reduce the risk of complications associated with type 2 diabetes, including heart disease, kidney problems, and nerve damage. Maintaining optimal blood glucose levels can also delay the onset of diabetic complications.
Weight Neutral:
- Unlike some other diabetes medications, metformin in Gliclaglaze M 40 has a neutral effect on weight. It is not associated with significant weight gain, a common concern for people with diabetes, especially those managing their condition with insulin and other medications.
Convenient Combination Therapy:
- Gliclaglaze M 40 offers the convenience of a single tablet that combines two effective medications. This simplifies the treatment regimen for individuals with type 2 diabetes, reducing the number of medications they need to take daily and improving adherence to the treatment plan.
Cardiovascular Benefits:
- Metformin has been shown to have cardioprotective effects. Regular use of Gliclaglaze M 40 can lower the risk of cardiovascular events, which are more common in people with type 2 diabetes. It helps improve lipid profiles and supports heart health.
Conclusion
Gliclaglaze M 40, with its combination of gliclazide (40 mg) and metformin (500 mg), is an effective solution for managing type 2 diabetes. The dual-action mechanism of these medications helps regulate both insulin secretion and insulin sensitivity, providing comprehensive blood glucose control. This combination not only improves glycemic control but also reduces the risk of long-term complications such as heart disease, kidney failure, and neuropathy.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
